By DAVID GELLES
The drug maker increased its bid to $33 billion as it seeks to fend off an unsolicited takeover offer from the Israeli pharmaceutical company Teva.
Published: April 25, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1DkhhDY
from WordPress http://ift.tt/1DkkKT3
via Hadi Aboukhater
No comments:
Post a Comment